The Net Margin of Transgene Biotek Ltd (526139.BO) is -259.34%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-03-31 | -259.34% |
| 2024-03-31 | -279.05% |
| 2023-03-31 | -10907.87% |
| 2022-03-31 | -11998.39% |
| 2021-03-31 | -6154.34% |
| 2020-03-31 | -306636.00% |
| 2019-03-31 | -12334.25% |
| 2018-03-31 | -5445.25% |
| 2017-03-31 | -7071.71% |
| 2016-03-31 | -11864.40% |